Emergency Medicine Doctors in Damariscotta, ME Accepting Medicare

6 Emergency Medicine doctors found. Showing 1 - 6

Timothy R Fox, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 35 Miles St., Miles Medical Group, Damariscotta, ME 04543 Phone: 207-563-4521    Fax: 207-563-3717

Alexander L Mesrobian, MD Emergency Medicine - Emergency Medical Services Medicare: Medicare Enrolled Practice Location: 35 Miles St, Miles Medical Group Emergency Dept, Damariscotta, ME 04543 Phone: 207-563-4521    Fax: 207-563-3717

Janet Ross Fowle, MD Emergency Medicine - Emergency Medical Services Medicare: Medicare Enrolled Practice Location: 35 Miles St, Damariscotta, ME 04543 Phone: 207-563-4521    Fax: 207-563-3717

Don W Gow Jr., DO Emergency Medicine - Emergency Medical Services Medicare: Not Enrolled in Medicare Practice Location: 35 Miles St, Miles Medical Group Emergency Dept, Damariscotta, ME 04543 Phone: 207-563-4521    Fax: 207-563-3717

Daniel J. Bates, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 35 Miles Street, Damariscotta, ME 04543 Phone: 207-563-4521    Fax: 207-563-4103

James Li, M.D. Emergency Medicine - Emergency Medical Services Medicare: Medicare Enrolled Practice Location: 35 Miles St, Miles Medical Group, Damariscotta, ME 04543 Phone: 207-563-4521    Fax: 207-563-3717

News Archive

AARP recommends older adults to get seasonal flu vaccination this year

With the thermometer dropping and the onset of flu season upon us, AARP is reaching out to their membership and the public to encourage them to get a seasonal flu vaccine this year.

Functional connectome of fetal brain begins to take form in utero

The fundamental organization of brain networks is established in utero during the second and third trimesters of fetal development, according to research published in JNeurosci. The finding lays the groundwork for understanding how the prenatal period shapes future brain function.

FDA approves Regeneron antibody drug as first treatment for Ebola virus

Today, the U.S. Food and Drug Administration approved Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn), a mixture of three monoclonal antibodies, as the first FDA-approved treatment for Zaire ebolavirus (Ebola virus) infection in adult and pediatric patients.

Six research teams awarded grant to accelerate discovery of new drugs for brain, nervous system disorders

CQDM, Brain Canada and the Ontario Brain Institute award close to $8.5M to six (6) multi-disciplinary and multi-provincial research teams across Canada to address unmet needs in neuroscience within their Focus on Brain strategic initiative. To this amount, $1.5M is added from the various research entities involved as in-kind contributions.

Institutional discrimination and people's attitudes affect disabled children

Many disabled children fail to reach their full potential because they continue to be marginalised in schools, health and social care, according to new research funded by the Economic and Social Research Council (ESRC).

Read more Medical News

› Verified 1 days ago